CVS Health Corporation

Market Cap (Mar-08-2026)

99.131 Billion USD

World Rank (Jan-05-2024)

136

Market Cap (Jan-05-2024)

104.084 Billion USD

World Rank (Jul-30-2023)

155

Market Cap (Jul-30-2023)

95.652 Billion USD

World Rank (Jan-07-2022)

99

Market Cap (Jan-07-2022)

137.540 Billion USD

World Rank (Jan-01-2021)

154

Market Cap (Jan-01-2021)

89.399 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 89

Headquarters Country

USA

Nasdaq / NYSE Code

CVS

CEO

Chairman

Founders

Employee Count

300,000

Employee Count as of Date

As on 2022

Headquarters City/State

Rhode Island

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

402,067 Million USD

Annual Operating Income in USD

4,660 Million USD

Annual Net Income in USD

1,768 Million USD

Annual Results for Period Ending

Dec-2025 ending year

Total Assets in USD

253,538 Million USD

Total Liabilities in USD

178,156 Million USD

Total Equity in USD

75,382 Million USD

Balance Sheet for Period Ending

Dec-2025 ending year

Business Sector

Company Website

CVS Health Corporation - Healthcare - Retail Pharmacy

Wikipedia

Yahoo

Yahoo @ NYSE

Company Profile

CVS Health Corporation is USA Based Healthcare Company and its services include Retail Pharmacy, Pharmacy Benefits Management, Clinical Services, Specialty Pharmacy, Digital Services. Headquarters is in USA.

CVS Health Corporation have three segments:

Health Care Benefits:

The Health Care Benefits segment offers a broad range of traditional, voluntary, and consumer-directed health insurance products and related services, including:

medical, pharmacy, dental, and behavioral health plans

medical management capabilities

Medicare Advantage and Medicare Supplement plans n Prescription Drug Plans (PDP)

Medicaid health care management services n health information technology products and services.

Pharmacy Services.

The Pharmacy Services segment provides a full range of pharmacy benefit management (PBM) solutions, including:

plan design offerings and administration.

formulary management n retail pharmacy network management services.

mail order pharmacy.

specialty pharmacy and infusion services n clinical services n disease management services.

medical spend management.

Retail/Long-Term Care:

The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, and:

provides health care services through its walk-in medical clinics.

provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19, and shingles.

conducts LTC operations, which distribute prescription drugs and provide other ancillary services to chronic care facilities and other care settings.

COVID-19 vaccines and 32+ million COVID-19 tests administered: 59 million.
Members with Aetna and Caremark: 100 million.
9,000 retail locations with 1,200 walk-in clinics.
4.5 million consumers visit CVS Health locations daily.
2.4% overall drug trend and 5.8% specialty trend through as on 2021.
4,000+ nurse practitioners and physician assistants currently employed.
40 million unique digital customers.
19 million virtual visits across CVS and Aetna in 2021, including 10 million behavioral health visits.

Facts About Company

As on 2022, CVS Health Corporation has 300,000 employees.

CVS Health Corporation annual revenue generated for period ending Dec-2022 was 322,467 million USD.

CVS Health Corporation annual net income generated for period ending Dec-2022 was 4,149 million USD.

As on 2021, CVS Health Corporation has 29,5000 employees.

CVS Health Corporation annual revenue generated for period ending Dec-2021 was 46,385 million USD.

Split of Regional Revenue by business segment for period ending Dec-2021:

Products: 203,738 million USD.
Premiums: 76,132 million USD.
Services: 11,042 million USD.
Net investment income: 1,199 million USD.

CVS Health Corporation annual net income generated for period ending Dec-2021 was 7,910 million USD.

Annual Results Summary

CVS HEALTH CORPORATION - Annual Results - Revenue and Net Profit - in Million USD:

Year - Ending	Revenue	Operating Income	Net Income
Dec-2023	357,776	14,599	8,344
Dec-2022	322,467	16,082	4,149
Dec-2021	292,111	14,982	7,910
Dec-2020	268,706	13,911	7,179
Dec-2019	156,776	11,987	6,634
Dec-2018	194,579	10,170	-594 (Loss)
Dec-2017	184,765	9,517	6,622

Balance Sheet Summary

CVS HEALTH CORPORATION - Balance Sheet Summary - in Million USD:

Year Ending:	Total Assets	Total Liabilities	Total Equity
Dec-2023	249,728	173,092	76,636
Dec-2022	228,275	156,960	71,315
Dec-2021	232,999	157,618	75,381
Dec-2020	230,715	161,326	69,389
Dec-2019	222,449	158,585	63,864
Dec-2018	196,456	138,231	58,225
Dec-2017	95,131	57,440	37,691
Dec-2016	94,462	57,632	36,830

Founded Year

1996

Institutional Investors

Top 30 Institutional Holder Names in CVS HEALTH CORPORATION as on SEP-30-2023

RANK	INSTITUTION NAME	DATE	SHARES HELD	CHANGE (SHARES)	CHANGE (%)	VALUE (IN 1,000S)
1	VANGUARD GROUP INC	09/30/2023	11,71,62,626	4,85,744	0.42%	$8,099,452
2	BLACKROCK INC.	09/30/2023	8,67,33,963	-70,00,887	-7.47%	$5,995,919
3	STATE STREET CORP	09/30/2023	5,40,99,124	-17,78,263	-3.18%	$3,739,872
4	CAPITAL WORLD INVESTORS	09/30/2023	4,04,25,071	99,34,269	32.58%	$2,794,585
5	MORGAN STANLEY	09/30/2023	3,11,14,704	-21,38,720	-6.43%	$2,150,959
6	FMR LLC	09/30/2023	2,74,87,238	61,94,441	29.09%	$1,900,193
7	DODGE & COX	09/30/2023	2,67,22,982	1,06,98,560	66.76%	$1,847,360
8	GEODE CAPITAL MANAGEMENT, LLC	09/30/2023	2,39,30,130	6,04,843	2.59%	$1,654,290
9	CAPITAL INTERNATIONAL INVESTORS	09/30/2023	2,28,53,897	2,00,33,737	710.38%	$1,579,890
10	BANK OF AMERICA CORP /DE/	09/30/2023	1,64,10,362	-1,40,757	-0.85%	$1,134,448
11	INVESCO LTD.	09/30/2023	1,60,95,890	-9,06,597	-5.33%	$1,112,709
12	NORGES BANK	12/31/2022	1,52,95,808	8,59,805	5.96%	$1,057,399
13	JPMORGAN CHASE & CO	09/30/2023	1,44,03,752	-5,56,680	-3.72%	$995,731
14	NORTHERN TRUST CORP	09/30/2023	1,42,14,296	3,05,564	2.20%	$982,634
15	ROYAL BANK OF CANADA	09/30/2023	1,41,36,920	3,05,112	2.21%	$977,285
16	CAPITAL RESEARCH GLOBAL INVESTORS	09/30/2023	1,34,32,649	77,95,109	138.27%	$928,599
17	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	09/30/2023	1,27,17,825	3,24,391	2.62%	$879,183
18	GOLDMAN SACHS GROUP INC	09/30/2023	1,15,42,907	-6,86,159	-5.61%	$797,961
19	PRICE T ROWE ASSOCIATES INC /MD/	09/30/2023	1,07,07,037	9,42,795	9.66%	$740,177
20	BANK OF NEW YORK MELLON CORP	09/30/2023	1,06,78,078	2,66,650	2.56%	$738,176
21	FRANKLIN RESOURCES INC	09/30/2023	1,04,19,011	-6,26,293	-5.67%	$720,266
22	LEGAL & GENERAL GROUP PLC	09/30/2023	96,01,953	-2,93,403	-2.97%	$663,783
23	NORDEA INVESTMENT MANAGEMENT AB	09/30/2023	95,43,017	-2,98,811	-3.04%	$659,709
24	DIMENSIONAL FUND ADVISORS LP	09/30/2023	95,32,084	-1,75,420	-1.81%	$658,953
25	UBS GROUP AG	09/30/2023	76,94,134	-8,42,844	-9.87%	$531,895
26	HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC	09/30/2023	68,49,086	5,15,325	8.14%	$473,477
27	MACQUARIE GROUP LTD	09/30/2023	63,30,317	-1,90,378	-2.92%	$437,615
28	UBS ASSET MANAGEMENT AMERICAS INC	09/30/2023	63,21,510	-3,14,000	-4.73%	$437,006
29	AMERIPRISE FINANCIAL INC	09/30/2023	63,03,199	-24,74,949	-28.19%	$435,740
30	BARCLAYS PLC	09/30/2023	59,03,870	4,20,716	7.67%	$408,135